Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Wissel

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
Stroke|October 7, 2000
A randomized, double-blind, placebo-controlled, dose-ranging study to compare the efficacy and safety of three doses of botulinum toxin type A (Dysport) with placebo in upper limb spasticity after strokeA M Bakheit, A F Thilmann, A B Ward, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 16, 2000
Botulinum toxin (Dysport) treatment of hip adductor spasticity in multiple sclerosis: a prospective, randomised, double blind, placebo controlled, dose ranging studyN Hyman, M Barnes, B Bhakta, et al.
Der Nervenarzt|November 17, 2010
[Botulinum toxin in the treatment of adult spasticity. An interdisciplinary German 10-point consensus 2010]J Wissel, M auf dem Brinke, M Hecht, et al.
Journal of Neurology|May 16, 2002
Efficacy and safety of a standardised 500 unit dose of Dysport (clostridium botulinum toxin type A haemaglutinin complex) in a heterogeneous cervical dystonia population: results of a prospective, multicentre, randomised, double-blind, placebo-controlled, parallel group studyJ Wissel, P Kanovsky, E Ruzicka, et al.
Journal of the American College of Cardiology|February 17, 2000
Survival with full neurologic recovery and no cerebral pathology after prolonged cardiopulmonary resuscitation with vasopressin in pigsV Wenzel, K H Lindner, A C Krismer, et al.
Gait & Posture|February 9, 2000
Recommendations for the use of botulinum toxin type A in the management of cerebral palsyH K Graham, K R Aoki, I Autti-Rämö, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
Stroke|October 7, 2000
A randomized, double-blind, placebo-controlled, dose-ranging study to compare the efficacy and safety of three doses of botulinum toxin type A (Dysport) with placebo in upper limb spasticity after strokeA M Bakheit, A F Thilmann, A B Ward, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 16, 2000
Botulinum toxin (Dysport) treatment of hip adductor spasticity in multiple sclerosis: a prospective, randomised, double blind, placebo controlled, dose ranging studyN Hyman, M Barnes, B Bhakta, et al.
Der Nervenarzt|November 17, 2010
[Botulinum toxin in the treatment of adult spasticity. An interdisciplinary German 10-point consensus 2010]J Wissel, M auf dem Brinke, M Hecht, et al.
Journal of Neurology|May 16, 2002
Efficacy and safety of a standardised 500 unit dose of Dysport (clostridium botulinum toxin type A haemaglutinin complex) in a heterogeneous cervical dystonia population: results of a prospective, multicentre, randomised, double-blind, placebo-controlled, parallel group studyJ Wissel, P Kanovsky, E Ruzicka, et al.
Journal of the American College of Cardiology|February 17, 2000
Survival with full neurologic recovery and no cerebral pathology after prolonged cardiopulmonary resuscitation with vasopressin in pigsV Wenzel, K H Lindner, A C Krismer, et al.
Gait & Posture|February 9, 2000
Recommendations for the use of botulinum toxin type A in the management of cerebral palsyH K Graham, K R Aoki, I Autti-Rämö, et al.
Pageof 7